When James was asked what were the 3 reasons for people to sit...

When James was asked what were the 3 reasons for people to sit up and take notice of Kazia Therapeutics, his response was:

1) Diversification - As James said Kazia never were an "all or nothing bet on 1 drug, 1 clinical trial". We have 9 clinical trials across 2 drugs in multiple disease areas. That means there are lots of irons in the fire and lots of opportunities to win.

2) We are Late Stage. We are in Human Trials. We are not one of those companies where everything is happening in the Lab or in mice. We have multiple data readouts, data from pivotal studies. We are at the pointy end of the game.

3) Huge Opportunities. Big prizes to win if successful. Commercial opportunities.

As Kerry Stevenson (Small Caps) said, "with 9 clinical trials, Kazia is not just balancing on 1 toe".

All this with a market cap of $35m ?????